Skip to main content
. 2021 Jan 24;12(2):91–97. doi: 10.14740/cr1194

Table 1. Blood Glucose Level and Heart Weight/Body Weight.

Control (n = 6) Linagliptin (n = 6) Empagliflozin (n = 9) Combination (n = 7)
Blood glucose (mg/dL)
  Day 0 397 ± 104 411 ± 106 441 ± 107 366 ± 79
  Day 14 598 ± 201 494 ± 184 320 ± 78* 300 ± 157*
  Day 35 660 ± 206 549 ± 180 478 ± 95a 522 ± 85
Heart weight/body weight on day 35 (%) 0.53 ± 0.04 0.50 ± 0.03 0.47 ± 0.06 0.48 ± 0.07

*P < 0.05, and aP < 0.10 by one-way analysis of variance with post-hoc comparison using Dunnett’s test.